HopeStage
Back to all studies
RecruitingNCT07405398

Smartwatch measures for opioid use and withdrawal in people taking opioids

About this titleRead the official source — NCT07405398
Device studyAges 22+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 22 years.

What will I do during this study?

You wear a wrist device during a 14-day outpatient monitoring period. The research team collects biometric data and time-stamped information about opioid medication use to train and assess a monitoring algorithm. The registry describes fitting and using a Samsung Galaxy Watch.

Listed locations
WilmingtonSee all locations and recruitment
Participation duration
The wrist-monitoring period lasts 14 days.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 1, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
420
Sponsor
OpiAID
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
Over 22 Years
Official registry ID
NCT07405398
Official title
Show the full official title

A Study to Train a Machine Learning Algorithm for an Evaluation of the Use of Biometric Data Captured at the Wrist for the Identification of Acute Opioid Use Events and the Quantification of Opioid Withdrawal in Opioid Dependent Individuals

Recruitment & locations

Currently recruiting

Wilmington

FAQ

Questions about this study

Who is behind this study?

The study sponsor is OpiAID.

Who can participate?

Listed age limits: from 22 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies